Health Canada has recalled a children's medication sold across due to the potential risk of overdose.
The recall was triggered by Teva Canada Ltd. after a routine product testing found "higher than acceptable amounts of acetaminophen in the affected lot."
The federal health agency is urging Canadians to verify if they have the recalled Pediatrix product and to stop using it, especially if their child begins to "show signs/symptoms of acetaminophen overdose."
Here are the specific details regarding the recalled product:
- Pediatrix (Acetaminophen Oral Solution) | 160 mg/5 ml | Lot MC0079 | Expires in August 2025
Pediatrix Acetaminophen Oral Solution for kids. Health Canada
The Pediatrix lots that are being recalled have approximately 185mg/5ml of acetaminophen when the approved dosage is 160mg/5ml.
"This could lead to children receiving too much acetaminophen. Children may be especially at risk of the effects of acetaminophen overdose given their small size and developing bodies," Health Canada indicated.
Although the company has not reported any illness or injury associated with the recall, Health Canada still shared the possible signs involving acetaminophen overdose.
"Signs of acetaminophen overdose include nausea, vomiting, lethargy, sweating, loss of appetite and pain in the upper part of the abdomen or stomach. Abdominal pain may be the first sign of liver damage and may not be apparent for 24 to 48 hours."
The health agency is currently monitoring the company's recall and is ensuring that corrective and preventative actions are being properly taken.
Health Canada is suggesting that Canadian consumers verify the lot number on any Pediatrix medication. If you do have it, it's recommended to "stop using the affected product," and return the product to your local pharmacy for proper disposal.
This article's cover image was used for illustrative purposes only.
